Clinical trials
Placebo - Control clinical trials
Below are recruiting placebo - control clinical trials, each written for real people, not researchers. We’re tracking 3,949 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07304089RecruitingPhase 2
Study of VIM0423 for people with dystonia
This trial tests an experimental drug called VIM0423 for people with isolated dystonia (a condition causing muscle spasms in multiple body parts). It aims to see if the drug can improve symptoms safely.
Birmingham, AlabamaAges 18–65 - NCT07305259RecruitingEarly Phase 1
Exercise as a cancer therapy aid
This study tests whether adding exercise to cancer treatment can help people. It's for people who are physically fit and don't have other health conditions or take certain medications.
Tallahassee, FloridaAges 18–45 - NCT07306754RecruitingPhase 1
A Safety Study of ABBV-243 in Healthy Adults
This study tests a new drug called ABBV-243 in healthy adults to see if it is safe and how the body processes it. Participation helps researchers understand the drug before studying it in people with a disease.
Grayslake, IllinoisAges 18–60 - NCT07307417Recruiting
Breathing muscle training for obesity
This trial tests if training your breathing muscles can improve respiratory function in people with obesity. It aims to help those with a BMI of 30 or higher.
Wroclaw, Dolny ŚląskAges 30–60 - NCT07309432RecruitingPhase 3
Birch allergy shot study for eye symptoms
This trial tests a new antibody treatment for eye allergy symptoms caused by birch pollen. It may help if you have severe eye allergies during birch season.
Andover, MassachusettsAges 12 years+ - NCT07310264RecruitingPhase 1
Safety study of a new drug for Parkinson's disease
This trial tests a new drug called VT-5006 to see if it is safe for people with Parkinson's disease. It focuses on those who have stomach or bowel issues, like constipation.
LeidenAges 18–80 - NCT07311395Recruiting
Gentamicin injection to prevent infection after planned C-section
This study tests whether a local injection of gentamicin, an antibiotic, into the incision area can help prevent infections after a planned C-section. It may offer extra protection beyond standard antibiotics.
NahariyaAges 18 years+ - NCT07311512Recruiting
Gum treatment and mouthwash study for gum disease
This trial tests if a professional gum cleaning combined with a special mouthwash can improve gum health and blood vessel function. It may help people with early gum disease who haven't had recent gum treatment.
Portsmouth, HampshireAges 30–75 - NCT07311564RecruitingPhase 2
Study of LAD603 for adults with severe alopecia areata
This trial tests a new medication called LAD603 for people with severe to very severe alopecia areata, a condition causing significant hair loss. It aims to see if the drug can help regrow hair.
Omaha, NebraskaAges 18–65 - NCT07312110RecruitingPhase 2
D-Serine for slowing Parkinson's disease progression
This study tests whether a supplement called D-serine can slow the progression of Parkinson's disease. It is for people diagnosed within the last 5 years who have mild to moderate symptoms and are not yet dependent on a wheelchair.
Arendal, AgderAges 40–80 - NCT07313722RecruitingPhase 1
Testing a new eye drop for safety in healthy volunteers
This trial tests whether a new eye drop called BT01001 is safe for healthy adults. You may join if you have good overall and eye health, and do not use contact lenses or have chronic eye problems.
ShanghaiAges 18–50 - NCT07314359Recruiting
Study of a biofield patch on antioxidants and energy
This study tests a special patch (called a biofield patch) to see if it can improve your body's antioxidant levels and energy. It involves several clinic visits with blood draws over a short time period.
Klamath Falls, OregonAges 18–75 - NCT07315061RecruitingPhase 2
Testing D-2570 for active psoriatic arthritis
This trial tests an oral medication, D-2570, for people with active psoriatic arthritis. It aims to see if the drug can reduce joint pain and swelling.
Chengdu, SichuanAges 18–70 - NCT07315516RecruitingPhase 2
Sleep and stress supplement study
This study tests a new supplement to help with sleep and stress. It is for adults who feel stressed and have sleep problems, but are otherwise healthy.
BrisbaneAges 18 years+ - NCT07316296RecruitingPhase 3
Testing a drug to reduce freezing of gait in Parkinson's
This trial tests whether atomoxetine, a drug that boosts a brain chemical called noradrenaline, can help reduce freezing of gait—a feeling of your feet being stuck to the ground—in people with Parkinson's disease. You would continue your usual Parkinson's medications during the study and undergo walking tests and brain scans to see if the drug helps.
Nijmegen, GelderlandAges 18 years+ - NCT07317544RecruitingPhase 1/Phase 2
Study of a new hair loss treatment in healthy adults
This trial tests a new medication called ABS-201 for hair loss. It will first see if the medicine is safe in healthy people, then test if it helps those with male or female pattern baldness.
Sydney, New South WalesAges 18–65 - NCT07318129Recruiting
Indole-3-propionic acid for multiple sclerosis
This trial tests an oral supplement called indole-3-propionic acid to see if it can help people with relapsing-remitting multiple sclerosis (RRMS). It involves taking the supplement daily and having regular MRI scans to monitor your MS.
Glostrup MunicipalityAges 18–65 - NCT07318675RecruitingPhase 1
Testing an ointment for actinic keratosis on the face
This trial tests an ointment called HW211026 for people with actinic keratosis, a common skin condition caused by sun damage. The study will check if the ointment is safe and works when applied to a 10 cm by 10 cm area on the face.
ShanghaiAges 18 years+ - NCT07319598RecruitingPhase 4
Tetrandrine tablets for connective tissue disease-related lung disease
This study tests if tetrandrine tablets can help people with lung disease caused by connective tissue disorders. It is for adults 18-80 who have stable treatment and meet specific health criteria.
BeijingAges 18–80 - NCT07322965Recruiting
Citicoline and DHA supplement for glaucoma patients
This trial tests whether a dietary supplement (DHA + citicoline) can help protect vision in people with glaucoma. You may qualify if you have confirmed glaucoma in at least one eye and are between 50 and 75 years old.
Barcelona, BarcelonaAges 50–75 - NCT07323524RecruitingPhase 4
Dapagliflozin for active lupus kidney disease
This study tests if a diabetes drug called dapagliflozin can help people with active lupus nephritis by reducing protein in the urine and preserving kidney function. It is given in addition to standard treatments.
Boston, MassachusettsAges 18–70 - NCT07324746Recruiting
Herbal supplement for osteoarthritis pain
This trial tests whether a herbal supplement helps people with osteoarthritis of the knee or hip feel less pain and move better. If you have moderate to severe pain and are able to walk, this study might be a good fit.
LondonAges 18 years+ - NCT07327281RecruitingPhase 1
Testing TQF3250 in healthy adults
This trial tests a new oral medication (TQF3250) in healthy adults to see how safe it is and how the body processes it. If you are a generally healthy Chinese volunteer, you may be able to help researchers learn about this potential treatment.
Nanjing, JiangsuAges 18–55 - NCT07327359RecruitingPhase 1/Phase 2
Study of OLX72021 for male pattern baldness
This trial tests an investigational drug called OLX72021 for male pattern hair loss (androgenetic alopecia). It aims to see if the drug is safe and effective in healthy men with mild to moderate hair loss.
Camberwell, VictoriaAges 18–59
Hear when a new Placebo - Control trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo - control?
- Yes. Clin2 currently lists 3,949 recruiting placebo - control studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo - control trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo - control trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.